The corporate history of the South African Tuberculosis Vaccine Initiative is available online. This history is the result of more than 20 interviews conducted over a period of about one year with SATVI staff and students, including many colleagues who have left, but are very much still part of the SATVI TB research family.
SATVI's research officer Dr Virginie Rozot, has been awarded a multi‑year contract from the Wellcome Leap’s Delta Tissue (∆T) programme to study human immune system’s response to the tuberculosis (TB) bacterium, in the human thoracic lymph nodes.
SATVI researchers have published a journal article titled: "Radiological and functional evidence of the bronchial spread of tuberculosis: an observational analysis" appearing in the Lancet Microbe journal.
SATVI researchers have published journal article titled: "Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial" appearing in The Lancet Infectious Diseases journal.